GRADE Analysis: quality assessment of adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia.

*Decrease quality of evidence: a) single-blind method; b) randomization by the antipsychotic weight; c). I2>50%; $Increase quality of evidence: d) RR >5 or GRADE Working Group grades of evidence: # High quality: Further research is very unlikely to change our confidence in the estimate of effect. Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very low quality: We are very uncertain about the estimate.